The Xolair Pregnancy Registry (EXPECT): Perinatal outcomes among pregnant women with asthma treated with omalizumab (Xolair) compared against those of a cohort of pregnant women with moderate-to-severe asthma

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 143; no. 2; p. AB103
Main Authors Namazy, Jennifer A., Blais, Lucie, Andrews, Elizabeth B., Scheuerle, Angela E., Cabana, Michael D., Thorp, John M., Veith, Joachim H., Umetsu, Dale T., Sun, Diana, Kaufman, Derrick G., Covington, Deborah L., Mukhopadhyay, Santanu, Fogel, Robert B., Lopez-Leon, Sandra, Spain, Vic
Format Journal Article
LanguageEnglish
Published St. Louis Elsevier Inc 01.02.2019
Elsevier Limited
Subjects
Asthma
Congenital diseases
Health risk assessment
Immunoglobulin E
Immunotherapy
Monoclonal antibodies
Pregnancy
Womens health
Canada
Quebec Canada
Online AccessGet full text

Cover

More Information
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2018.12.312